{"content":"<li class=\"n-box-item date-title\" data-end=\"1497326399\" data-start=\"1497240000\" data-txt=\"Monday, December 23, 2019\">Monday, June 12, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3273037\" data-ts=\"1497303342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273037-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/AHH' title='Armada Hoffler Properties, Inc.'>AHH</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/BVN' title='Compañía de Minas Buenaventura S.A.A.'>BVN</a> <font color='green'>+2.4%</font>. <a href='https://seekingalpha.com/symbol/PUMP' title='ProPetro'>PUMP</a> <font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/EXTR' title='Extreme Networks, Inc.'>EXTR</a> <font color='green'>+1.7%</font>. <a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a> <font color='green'>+1.7%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-11.3%</font>. <a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a> <font color='red'>-5.1%</font>. <a href='https://seekingalpha.com/symbol/SYNA' title='Synaptics Incorporated'>SYNA</a> <font color='red'>-2.2%</font>. <a href='https://seekingalpha.com/symbol/FR' title='First Industrial Realty Trust, Inc.'>FR</a> <font color='red'>-1.8%</font>. <a href='https://seekingalpha.com/symbol/BSAC' title='Banco Santander-Chile'>BSAC</a> <font color='red'>-1.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273037\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AHH $BVN $PUMP - After Hours Gainers / Losers https://seekingalpha.com/news/3273037-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3273037-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273034\" data-ts=\"1497302139\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIE\" target=\"_blank\">CIE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273034-cobalt-energy-oks-1-forminus-15-reverse-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cobalt Energy OKs 1-for-15 reverse split</a></h4><ul>     <li>Cobalt International Energy (NYSE:<a href='https://seekingalpha.com/symbol/CIE' title='Cobalt International Energy, Inc.'>CIE</a>) <font color='red'>-9.9%</font>&nbsp;AH after approving a 1-for-15 <a href=\"https://seekingalpha.com/pr/16859438-cobalt-international-energy-inc-board-directors-approves-reverse-stock-split\" target=\"_blank\">reverse stock split</a> to become effective after the market closes on or about June 23.</li>     <li>CIE took the action after <a href=\"https://seekingalpha.com/pr/16859438-cobalt-international-energy-inc-board-directors-approves-reverse-stock-split\" target=\"_blank\">violating</a> the NYSE's continued listing standard of a $1-plus average closing share price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273034\" data-linked=\"Cobalt Energy OKs 1-for-15 reverse split\" data-tweet=\"$CIE - Cobalt Energy OKs 1-for-15 reverse split https://seekingalpha.com/news/3273034-cobalt-energy-oks-1-forminus-15-reverse-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3273034-cobalt-energy-oks-1-forminus-15-reverse-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273031\" data-ts=\"1497301555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNA\" target=\"_blank\">SYNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273031-synaptics-announces-acquisitions-lowers-guidance-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synaptics announces acquisitions, lowers guidance; shares down 3%</a></h4><ul>     <li>        Synaptics (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNA' title='Synaptics Incorporated'>SYNA</a>) <a href=\"https://seekingalpha.com/pr/16859423-synaptics-accelerates-consumer-iot-strategy-acquisitions-conexant-systems-llc-multimedia\" target=\"_blank\">announces</a> the acquisitions of Conexant Systems and the Multimedia Solutions Business of Marvell Technology Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>).&nbsp;</li>     <li>        Conexant makes tech for video and audio processing in smart home systems.&nbsp;Conexant reported $104M in revenue last fiscal year.&nbsp;          </li>     <li>              Synaptics will pay $300M in cash and 726,666 in common stock for Conexant. </li>     <li> The Multimedia Solutions Business arm of Marvell also has video and audio processing but comes with a large IP portfolio and security capabilities that work well with set-top boxes and digital personal assistants. Revenue was $94M last year. </li>     <li> Synaptics will pay $95M in an all-cash offer for Marvell&rsquo;s Multimedia business.&nbsp; </li>     <li>        Synaptics has now lowered Q4 guidance to $420M to $430M in revenue compared to the previous estimate of $410M to $450M. Consensus estimates have revenue at $431.32M.&nbsp;</li>     <li>        Synaptics shares are&nbsp;<font color='red'>down over 3%</font>&nbsp;aftermarket.             </li>      </ul><div class=\"tiny-share-widget\" data-id=\"3273031\" data-linked=\"Synaptics announces acquisitions, lowers guidance; shares down 3%\" data-tweet=\"$SYNA $SYNA $MRVL - Synaptics announces acquisitions, lowers guidance; shares down 3% https://seekingalpha.com/news/3273031-synaptics-announces-acquisitions-lowers-guidance-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3273031-synaptics-announces-acquisitions-lowers-guidance-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273021\" data-ts=\"1497300116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIC\" target=\"_blank\">SAIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273021-science-applications-misses-on-revenue-reports-low-margins-shares-down-11_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Science Applications misses on revenue, reports low margins; shares down 11.6%</a></h4><ul><li>        Science Applications (NYSE:<a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a>) Q1 report beat EPS estimates but missed on revenue. The year-over-year revenue drop was partly due to $25M in contract losses. Margins were below expectations due to higher costs and tech investments.</li><li>               Other key metrics include $88M in cash flow from operating activities, $84M in FCF, and $73M EBITDA.&nbsp;</li><li>               Dividend: Declared at $0.31 per share for stockholders of record by July 14, payable July 28.&nbsp;&nbsp;</li><li>               Science Application shares are&nbsp;<font color='red'>down 11.59%&nbsp;</font>aftermarket.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16859407-saic-announces-first-quarter-fiscal-year-2018-results\" target=\"_blank\">Press release</a>&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273013-science-applications-beats-0_04-misses-revenue\" target=\"_blank\">Science Applications beats by $0.04, misses on revenue</a> (June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273021\" data-linked=\"Science Applications misses on revenue, reports low margins; shares down 11.6%\" data-tweet=\"$SAIC - Science Applications misses on revenue, reports low margins; shares down 11.6% https://seekingalpha.com/news/3273021-science-applications-misses-on-revenue-reports-low-margins-shares-down-11_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3273021-science-applications-misses-on-revenue-reports-low-margins-shares-down-11_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273019\" data-ts=\"1497299769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273019-merck-pauses-enrollment-in-two-keytruda-combo-studies-in-multiple-myeloma-to-investigate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merck pauses enrollment in two Keytruda combo studies in multiple myeloma to investigate deaths; shares slip 1% after hours</a></h4><ul><li>Merck (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) is down&nbsp;<font color='red'>1%</font>&nbsp;after hours on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16859404-merck-provides-update-multiple-myeloma-studies-keynoteminus-183-185-keytruda-pembrolizumab\" target=\"_blank\">announcement </a>that it will pause new enrollment in two late-stage studies, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02576977?term=keynote-183&amp;rank=1\" target=\"_blank\">KEYNOTE-183</a> and <a href=\"https://clinicaltrials.gov/ct2/show/NCT02579863?term=keynote-185&amp;rank=1\" target=\"_blank\">KEYNOTE-185</a>, assessing KEYTRUDA (pembrolizumab) combination therapies in multiple myeloma. The company took action based on the recommendation of the external Data Monitoring Committee to halt new recruitment until it investigated deaths in the KEYTRUDA groups.</li><li>KEYNOTE-183 is evaluating the combination of KEYTRUDA and pomalidomide and dexamethasone.</li><li>KEYNOTE-185 is evaluating the combination of KEYTRUDA and lenalidomide and dexamethasone.</li><li>Other KEYTRUDA studies will continue unchanged.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273019\" data-linked=\"Merck pauses enrollment in two Keytruda combo studies in multiple myeloma to investigate deaths; shares slip 1% after hours\" data-tweet=\"$MRK - Merck pauses enrollment in two Keytruda combo studies in multiple myeloma to investigate deaths; shares slip 1% after hours https://seekingalpha.com/news/3273019-merck-pauses-enrollment-in-two-keytruda-combo-studies-in-multiple-myeloma-to-investigate?source=tweet\" data-url=\"https://seekingalpha.com/news/3273019-merck-pauses-enrollment-in-two-keytruda-combo-studies-in-multiple-myeloma-to-investigate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273009\" data-ts=\"1497298188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNMK\" target=\"_blank\">GNMK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273009-genmark-launches-65m-equity-offering-shares-down-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GenMark launches $65M equity offering; shares down 3% after hours</a></h4><ul><li>GenMark Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a>) <a href=\"https://seekingalpha.com/pr/16859353-genmark-diagnostics-commences-public-offering-common-stock\" target=\"_blank\">initiates </a>a $65M offering of common stock. Prce, volume and terms have yet to be announced.</li><li>Shares are down&nbsp;<font color='red'>3%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273009\" data-linked=\"GenMark launches $65M equity offering; shares down 3% after hours\" data-tweet=\"$GNMK - GenMark launches $65M equity offering; shares down 3% after hours https://seekingalpha.com/news/3273009-genmark-launches-65m-equity-offering-shares-down-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3273009-genmark-launches-65m-equity-offering-shares-down-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273008\" data-ts=\"1497298167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADC\" target=\"_blank\">ADC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273008-agree-realty-raising-equity-capital\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agree Realty raising equity capital</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16859361-agree-realty-announces-common-stock-offering\" target=\"_blank\">company is selling 2.1M shares</a> with underwriter greenshoe of 315K shares.</li><li>Immediate use of proceeds will be to pay down the revolver and acquisitions.</li><li><a href='https://seekingalpha.com/symbol/ADC' title='Agree Realty Corporation'>ADC</a> no trades after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3273008\" data-linked=\"Agree Realty raising equity capital\" data-tweet=\"$ADC - Agree Realty raising equity capital https://seekingalpha.com/news/3273008-agree-realty-raising-equity-capital?source=tweet\" data-url=\"https://seekingalpha.com/news/3273008-agree-realty-raising-equity-capital\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273006\" data-ts=\"1497298080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273006-nasdaq-composite-closes-down-tech-pullback-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nasdaq Composite closes down as tech pullback continues</a></h4><ul><li>        The tech sector continues the pullback that began on Friday. The tech-heavy Nasdaq Composite Index closed&nbsp;<font color='red'>down 0.52%</font>.&nbsp;</li><li>        Notable tech companies down at close include: Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>)&nbsp;<font color='red'>2.46%</font>; Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>):&nbsp;<font color='red'>0.78%</font>; Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>)&nbsp;<font color='red'>1.38%</font>; and Google (NASDAQ:<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>):&nbsp;<font color='red'>0.73%</font>.&nbsp;</li><li>        Meanwhile, Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+Comments/Tech+Sell-Off+Likely+Not+Over%2C+But+Money+Is+Not+Leaving+this+Bull+-+Morgan+Stanley/13001754.html\" target=\"_blank\">analyst</a> Michael Wilson notes that the correction was &ldquo;way overdue given the extreme outperformance and positioning in technology shares.&rdquo;</li><li>               Wilson expects the selling to continue but clarifies that this is a simple correction and not the bull market&rsquo;s end.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3273006\" data-linked=\"Nasdaq Composite closes down as tech pullback continues\" data-tweet=\"$AAPL $AAPL $FB - Nasdaq Composite closes down as tech pullback continues https://seekingalpha.com/news/3273006-nasdaq-composite-closes-down-tech-pullback-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3273006-nasdaq-composite-closes-down-tech-pullback-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272997\" data-ts=\"1497296181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHRS\" target=\"_blank\">CHRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272997-analysts-still-bullish-on-coherus-despite-crl-on-chsminus-1701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts still bullish on Coherus despite CRL on CHS-1701</a></h4><ul><li>Credit Suisse's Alethia Young does not appear too concerned about the FDA's rejection of Coherus Biosciences' (<a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a> <font color='red'>-25.2%</font>) NDA for CHS-1701, a biosimilar to Amgen's Neulasta (pegfilgrastim). She says it was not a \"worse case\" scenario although it means that potential regulatory clearance may be pushed out about a year. She is \"cautiously optimistic\" on management's timelines (OUTPERFORM/$38).</li><li>Cowen's Ken Cacciatore says the CRL \"appears resolvable\" but adds the delay in approval will be about a year (BUY/$45).</li><li>Citigroup's Mohit Bansal concurs (BUY/$38).</li><li>Source: Bloomberg email</li></ul><div class=\"tiny-share-widget\" data-id=\"3272997\" data-linked=\"Analysts still bullish on Coherus despite CRL on CHS-1701\" data-tweet=\"$CHRS - Analysts still bullish on Coherus despite CRL on CHS-1701 https://seekingalpha.com/news/3272997-analysts-still-bullish-on-coherus-despite-crl-on-chsminus-1701?source=tweet\" data-url=\"https://seekingalpha.com/news/3272997-analysts-still-bullish-on-coherus-despite-crl-on-chsminus-1701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272995\" data-ts=\"1497295146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPL\" target=\"_blank\">UPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272995-ultra-petroleum-upped-to-buy-stifel-after-emerging-stronger-from-reorg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultra Petroleum upped to Buy at Stifel after emerging stronger from reorg</a></h4><ul>     <li>Ultra Petroleum (<a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='green'>+3.3%</font>) is sharply higher after Stifel <a href=\"http://thefly.com/thestreet/realmoney/index.php/UPLid2565069/UPL-Ultra-Petroleum-upgraded-on-reorganization-at-Stifel\" target=\"_blank\">upgrades shares to Buy</a> from Hold with a $16 price target, up from $9, saying the company's reorganization has improved its balance sheet and margins while leaving it \"ready to compete.\"</li>     <li>UPL emerged from an in-court restructuring in April after  raising $2.98B in exit financing to pay creditors and in the process cut its debt by $1.9B and its transportation, processing and interest costs by $156M/year, and the firm now views UPL's improved balance sheet as strong with projected year-end 2017 debt/EBITDA of 2.4x.</li>     <li>Stifel says UPL's cost structure remains among the lowest of the gas-focused E&amp;P companies, and unlike most of its peers has generated positive earnings during the past two years.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3272995\" data-linked=\"Ultra Petroleum upped to Buy at Stifel after emerging stronger from reorg\" data-tweet=\"$UPL $UPLC - Ultra Petroleum upped to Buy at Stifel after emerging stronger from reorg https://seekingalpha.com/news/3272995-ultra-petroleum-upped-to-buy-stifel-after-emerging-stronger-from-reorg?source=tweet\" data-url=\"https://seekingalpha.com/news/3272995-ultra-petroleum-upped-to-buy-stifel-after-emerging-stronger-from-reorg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272991\" data-ts=\"1497294533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKD\" target=\"_blank\">BKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272991-long-term-care-stocks-shrug-off-broad-selling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Long-term care stocks shrug off broad selling</a></h4><ul><li>Healthcare companies specializing in long-term patient care are mostly up, ignoring the market's bearish mood. The iShares Nasdaq Biotechnology ETF (<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='red'>-0.3%</font>) is down a fraction on average volume as is the SPDR S&amp;P Health Care Services ETF (<a href='https://seekingalpha.com/symbol/XHS-OLD' title='SPDR S&P Health Care Services ETF'>XHS-OLD</a> <font color='red'>-0.3%</font>).</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/BKD' title='Brookdale Senior Living Inc.'>BKD</a> <font color='green'>+2.4%</font>)(<a href='https://seekingalpha.com/symbol/CSU' title='Capital Senior Living Corporation'>CSU</a> <font color='green'>+5.3%</font>)(<a href='https://seekingalpha.com/symbol/DVCR' title='Diversicare Healthcare Services Inc.'>DVCR</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/ENSG' title='The Ensign Group, Inc.'>ENSG</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/FVE' title='Five Star Senior Living, Inc.'>FVE</a> <font color='green'>+6.1%</font>)(<a href='https://seekingalpha.com/symbol/GEN' title='Genesis Healthcare, Inc.'>GEN</a> <font color='green'>+7.5%</font>)(<a href='https://seekingalpha.com/symbol/KND' title='Kindred Healthcare, Inc.'>KND</a> <font color='green'>+1.4%</font>)</li><li>Hospital operators, as a group are up as well.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='green'>+2%</font>)(<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a> <font color='green'>+1.7%</font>)(<a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <font color='green'>+1.7%</font>)(<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='green'>+6.9%</font>)(<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+2.3%</font>)(<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services Inc.'>UHS</a> <font color='green'>+1.9%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3272991\" data-linked=\"Long-term care stocks shrug off broad selling\" data-tweet=\"$BKD $IBB $XHS - Long-term care stocks shrug off broad selling https://seekingalpha.com/news/3272991-long-term-care-stocks-shrug-off-broad-selling?source=tweet\" data-url=\"https://seekingalpha.com/news/3272991-long-term-care-stocks-shrug-off-broad-selling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272988\" data-ts=\"1497294002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272988-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/MOBL' title='MobileIron, Inc.'>MOBL</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/MATR' title='Mattersight Corporation'>MATR</a> <font color='green'>+10%</font>. DRAM <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TLND' title='Talend SA'>TLND</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/KOPN' title='Kopin Corporation'>KOPN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CAMT' title='Camtek Ltd.'>CAMT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3272988\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$ABIL $CNTF $MOBL - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3272988-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3272988-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272977\" data-ts=\"1497290447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272977-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BIOA' title='BioAmber'>OTC:BIOA</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/USAC' title='USA Compression Partners, LP'>USAC</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272977\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$BIOA $GSV $ECR-OLD - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3272977-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3272977-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272975\" data-ts=\"1497290009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIT\" target=\"_blank\">WIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272975-wipro-clarifies-adr-ex-date-after-premarket-plunge-halt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wipro clarifies ADR ex-date after premarket plunge, halt</a></h4><ul><li>        Wipro (NYSE:<a href='https://seekingalpha.com/symbol/WIT' title='Wipro Limited'>WIT</a>) <a href=\"https://www.reuters.com/article/brief-wipro-issues-clarification-on-ex-d-idUSFWN1J90FM\" target=\"_blank\">issues</a> a clarification on the ex-date for ADR stock dividend after a premarket plunge followed by a temporary halt.</li><li>               Wipro says that the NYSE contacted the company, according to practice, after the morning&rsquo;s market activity.&nbsp;</li><li>               The company states that the payable and ex-dividend dates for the ADR bonus issue have not been determined yet.&nbsp;&nbsp;</li><li>Wipro shares are&nbsp;<font color='red'>down 3.16%</font>. &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3272975\" data-linked=\"Wipro clarifies ADR ex-date after premarket plunge, halt\" data-tweet=\"$WIT - Wipro clarifies ADR ex-date after premarket plunge, halt https://seekingalpha.com/news/3272975-wipro-clarifies-adr-ex-date-after-premarket-plunge-halt?source=tweet\" data-url=\"https://seekingalpha.com/news/3272975-wipro-clarifies-adr-ex-date-after-premarket-plunge-halt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272974\" data-ts=\"1497289775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272974-bank-of-canada-official-talks-rate-hike-loonie-surges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank of Canada official talks rate hike -  loonie surges</a></h4><ul><li>\"There are encouraging signs that growth is broadening across regions and sectors,\" <a href=\"http://www.bankofcanada.ca/2017/06/canadian-economy-showing-encouraging-signs/\" target=\"_blank\">says Senior Deputy Governor Carolyn Wilkins</a>.</li><li>The bank, she says, must be preemptive.&nbsp;&ldquo;If you saw a stop light ahead, you would begin letting up on the gas to slow down smoothly ...&nbsp;You don&rsquo;t want to have to slam on the brakes at the last second. Monetary policy must also anticipate the road ahead.&rdquo;</li><li>The loonie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>) has moved up vs. the dollar by about 100 pips, now&nbsp;<font color='green'>ahead 1.4%</font>&nbsp;on the session to $0.7482. Stocks in Toronto are<font color='red'> down 0.5%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/CNDA' title='IQ Canada Small Cap ETF'>CNDA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Currency Hedged MSCI Canada ETF'>HEWC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3272974\" data-linked=\"Bank of Canada official talks rate hike -  loonie surges\" data-tweet=\"$FXC $EWC $CNDA - Bank of Canada official talks rate hike - loonie surges https://seekingalpha.com/news/3272974-bank-of-canada-official-talks-rate-hike-loonie-surges?source=tweet\" data-url=\"https://seekingalpha.com/news/3272974-bank-of-canada-official-talks-rate-hike-loonie-surges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272971\" data-ts=\"1497289417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTCS\" target=\"_blank\">BTCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272971-red-hot-cryptocurrency-rally-takes-breather\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red-hot cryptocurrency rally takes a breather</a></h4><ul> <li>Cryptocurrency Ethereum is <font color='red'>down 16%</font> and Bitcoin is <font color='red'>off 15%</font> as they finally take a breather after prodigious runs to all-time highs.</li> <li>Ethereum has seen red-hot demand from South Korea of late, while traders in Japan are still underpinning the extended Bitcoin rally. Some industry insiders say Ethereum is looking a little bubbly due to the company's use of ICOs (unique capital-raising tokens).</li> <li>Related tickers: <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3272971\" data-linked=\"Red-hot cryptocurrency rally takes a breather\" data-tweet=\"$BTCS $COIN $BTCS - Red-hot cryptocurrency rally takes a breather https://seekingalpha.com/news/3272971-red-hot-cryptocurrency-rally-takes-breather?source=tweet\" data-url=\"https://seekingalpha.com/news/3272971-red-hot-cryptocurrency-rally-takes-breather\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272970\" data-ts=\"1497289039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YZC\" target=\"_blank\">YZC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272970-chinas-yancoal-gets-regulatory-ok-for-rio-tinto-deal-glencore-swoops-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China&#39;s Yancoal gets regulatory OK for Rio Tinto deal as Glencore swoops in</a></h4><ul>     <li>China's Yancoal (<a href='https://seekingalpha.com/symbol/YZC' title='Yanzhou Coal Mining Co. Ltd.'>YZC</a>, <a href='https://seekingalpha.com/symbol/YACAF' title='Yancoal Australia Ltd'>OTC:YACAF</a>) has gained <a href=\"http://www.reuters.com/article/us-riotinto-m-a-yancoal-idUSKBN1920N2\" target=\"_blank\">Chinese regulatory approval</a> for its $2.45B purchase of Rio Tinto's (<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='red'>-1.8%</font>) Australian coal unit, the company said in a weekend stock exchange filing that also acknowledged Glencore's (<a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore Plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore Plc ADR'>OTCPK:GLNCY</a>) <a href=\"https://seekingalpha.com/news/3272711-glencore-crashes-chinese-deal-rio-tintos-australian-coal-2_5b-bid\" target=\"_blank\">$2.55B counterbid</a> for the assets.</li>     <li>Glencore's proposal is $100M higher and fully funded, but the terms of the deal say Rio must give Yancoal the chance to make a counter offer, opening the way for a bidding war.</li>     <li>&ldquo;The Glencore decision puts Rio Tinto in a <a href=\"https://www.bloomberg.com/news/articles/2017-06-12/china-coal-giant-awaits-rio-response-to-glencore-s-rival-offer\" target=\"_blank\">very difficult situation</a>,&rdquo; says Argonaut Securities analyst Helen Lau. &ldquo;It&rsquo;s hard for the board to reject a higher offer, with better terms, but at the same time, it could be even more difficult to reject Yanzhou Coal, which has got almost all government clearance for the deal.\"</li>     <li>Analysts like Glencore's move because of the <a href=\"https://www.ft.com/content/f6853485-3c26-3b90-8244-c47342acf9dd\" target=\"_blank\">potential to cut costs and raise productivity</a>; Tyler Broda at RBC Securities says the deal would boost Glencore&rsquo;s  production in the Hunter Valley by ~50% to 81M metric tons/year and was reasonably priced.</li>     <li>If Glencore&rsquo;s bid succeeds, the company says it also would seek to buy Mitsubishi&rsquo;s stakes in two coal ventures in the same area for $920M, and would sell at least $1.5B in assets to mitigate the cost.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3272970\" data-linked=\"China&#39;s Yancoal gets regulatory OK for Rio Tinto deal as Glencore swoops in\" data-tweet=\"$YZC $YZC $YACAF - China&#39;s Yancoal gets regulatory OK for Rio Tinto deal as Glencore swoops in https://seekingalpha.com/news/3272970-chinas-yancoal-gets-regulatory-ok-for-rio-tinto-deal-glencore-swoops-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3272970-chinas-yancoal-gets-regulatory-ok-for-rio-tinto-deal-glencore-swoops-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272969\" data-ts=\"1497288427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZUL\" target=\"_blank\">AZUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272969-azul-updates-on-traffic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Azul updates on traffic</a></h4><ul> <li>Azul (<a href='https://seekingalpha.com/symbol/AZUL' title='Azul'>AZUL</a> <font color='red'>-1.1%</font>) reports passenger traffic increased 20.4% Y/Y to 1.614B kilometers in May..</li> <li>Capacity was up 20.0% to 2.022B available seat miles during the month.</li> <li>Total May load factor +20 bps to 79.8%. Domestic load factor -50 bps to 78.0%. International load capacity +240 bps to 89.6%.</li> <li>Shares of Azul are up 3.24% from the level the IPO priced in the U.S.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3272969\" data-linked=\"Azul updates on traffic\" data-tweet=\"$AZUL - Azul updates on traffic https://seekingalpha.com/news/3272969-azul-updates-on-traffic?source=tweet\" data-url=\"https://seekingalpha.com/news/3272969-azul-updates-on-traffic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272961\" data-ts=\"1497287900\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272961-tandem-diabetes-advances-plgs-algorithm-u-s-marketing-application-on-tap-for-this-year-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem Diabetes advances PLGS algorithm, U.S. marketing application on tap for this year; shares ahead 8%</a></h4><ul><li>Thinly traded nano cap Tandem Diabetes Care (<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='green'>+8%</font>) perks up on slightly higher volume in response to <a href=\"https://seekingalpha.com/pr/16859121-tandem-diabetes-care-presents-findings-predictive-low-glucose-suspend-plgs-feasibility-study\" target=\"_blank\">positive results</a> from a small overnight hospital-based study assessing its new algorithm to automatically control the delivery of glucose when a patient has low blood sugar when using its continuous insulin delivery system. The data were presented at the 77th Scientific Sessions of the American Diabetes Association in San Diego, CA.</li><li>10 type 1 diabetics were started on the company's predictive low glucose suspend &#40;PLGS&#41; algorithm. Low glucose was induced via increased basal insulin overnight. &nbsp;The system successfully suspended the delivery of insulin when continuous glucose monitoring &#40;CGM&#41; values were predicted to be below 80 mg/dL in the next 30 minutes. Insulin delivery resumed when CGM values began to rise. No hypoglycemic events were observed.</li><li>CEO Kim Blickenstaff says, &ldquo;The results from this feasibility study are very encouraging. The IDE for our pivotal trial, which will use the predictive low glucose suspend algorithm on a t:slim X2&trade; Pump with Dexcom G5&reg; Mobile CGM integration, was approved by the FDA in May, and we look forward to starting enrollment soon. Our goal remains to submit our t:slim X2 Pump with predictive low glucose suspend to the FDA later this year, and we continue to plan for launch of this product in early 2018, subject to FDA approval.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3272961\" data-linked=\"Tandem Diabetes advances PLGS algorithm, U.S. marketing application on tap for this year; shares ahead 8%\" data-tweet=\"$TNDM - Tandem Diabetes advances PLGS algorithm, U.S. marketing application on tap for this year; shares ahead 8% https://seekingalpha.com/news/3272961-tandem-diabetes-advances-plgs-algorithm-u-s-marketing-application-on-tap-for-this-year-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3272961-tandem-diabetes-advances-plgs-algorithm-u-s-marketing-application-on-tap-for-this-year-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272965\" data-ts=\"1497287126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIEN\" target=\"_blank\">SIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272965-sientra-takes-out-miramar-labs-for-up-to-34m-mrlb-down-71\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sientra takes out Miramar Labs for up to $34M; MRLB down 71%</a></h4><ul><li>Medical aesthetics firm Sientra (<a href='https://seekingalpha.com/symbol/SIEN' title='Sientra'>SIEN</a> <font color='green'>+1.2%</font>) inks an <a href=\"https://seekingalpha.com/pr/16858610-sientra-acquire-miramar-labs\" target=\"_blank\">agreement </a>to acquire Miramar Labs (<a href='https://seekingalpha.com/symbol/MRLB' title='Miramar Labs Inc'>OTCQB:MRLB</a> <font color='red'>-71.4%</font>) for $20M in upfront cash and up to $14M in milestone-related cash, which looks like a bargain compared to Friday's close of $1.40.</li><li>Under the terms of the deal, Sientra will pay $0.3149/share of Miramar stock after settling debt and other obligations. Miramar will have the right to receive up to $0.7058/shares upon the achievement of certain milestones.</li><li>Miramar's top product is the <a href=\"http://miramarlabs.com/about-miradry-system/technology/\" target=\"_blank\">miraDry </a>system which uses microwave energy to destroy sweat glands under the arms as a way to control sweating.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272965\" data-linked=\"Sientra takes out Miramar Labs for up to $34M; MRLB down 71%\" data-tweet=\"$SIEN $SIEN $MRLB - Sientra takes out Miramar Labs for up to $34M; MRLB down 71% https://seekingalpha.com/news/3272965-sientra-takes-out-miramar-labs-for-up-to-34m-mrlb-down-71?source=tweet\" data-url=\"https://seekingalpha.com/news/3272965-sientra-takes-out-miramar-labs-for-up-to-34m-mrlb-down-71\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272963\" data-ts=\"1497286836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272963-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FSBK' title='First South Bancorp Inc'>FSBK</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CMCT' title='CIM Commercial Trust Corp.'>CMCT</a> <font color='green'>+8%</font>.<a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/WDR' title='Waddell & Reed Financial Inc'>WDR</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CRF' title='Cornerstone Total Return Fund'>CRF</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CLM' title='Cornerstone Strategic Value Fund'>CLM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MBTF' title='M B T Financial Corp'>MBTF</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/TREE' title='LendingTree, Inc.'>TREE</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272963\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$FSBK $CMCT $LEJU - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3272963-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3272963-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272959\" data-ts=\"1497285928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272959-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='green'>+50%</font>. <a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/MLSS' title='Milestone Scientific Inc.'>MLSS</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/NK' title='NantKwest'>NK</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MRTX' title='Mirati Therapeutics, Inc.'>MRTX</a> <font color='green'>+13%</font>. WCST <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/GDEN' title='Golden Entertainment, Inc.'>GDEN</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/VISI' title='Volt Information Sciences, Inc.'>VISI</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CRF' title='Cornerstone Total Return Fund'>CRF</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ONVI' title='Onvia, Inc.'>ONVI</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NDLS' title='Noodles & Company'>NDLS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3272959\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ONCT $XBIT $MLSS - Midday Gainers / Losers https://seekingalpha.com/news/3272959-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3272959-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272958\" data-ts=\"1497285746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRO\" target=\"_blank\">TSRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272958-gilead-and-sanofi-eyeing-tesaro-streetinsider\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead and Sanofi eyeing TESARO - StreetInsider</a></h4><ul><li><a href=\"https://www.streetinsider.com/Hot+M+and+A/Sanofi+%28SNY%29%2C+One+Other+Bidder+Said+to+Examine+%2410B+Deal+for+Tesaro+%28TSRO%29+-+Source/13001951.html\" target=\"_blank\">Takeover rumors</a> have been flying about ever since the FDA approved TESARO's (<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='green'>+2.3%</font>) PARP inhibitor Zejula (niraparib) in March. Interest is not one-sided. The company has been reaching out to potential suitors about a deal, but supposedly interest has been muted.</li><li>In the latest go round, Sanofi (<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a> <font color='red'>-2%</font>) and Gilead Sciences (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='green'>+1.1%</font>) are eyeing the company, which could fetch $10B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270821-tesaro-exploring-sale-shares-4-percent-hours\" target=\"_blank\">TESARO exploring sale; shares up 4% after hours</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3272958\" data-linked=\"Gilead and Sanofi eyeing TESARO - StreetInsider\" data-tweet=\"$TSRO $TSRO $SNY - Gilead and Sanofi eyeing TESARO - StreetInsider https://seekingalpha.com/news/3272958-gilead-and-sanofi-eyeing-tesaro-streetinsider?source=tweet\" data-url=\"https://seekingalpha.com/news/3272958-gilead-and-sanofi-eyeing-tesaro-streetinsider\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272957\" data-ts=\"1497285465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNR\" target=\"_blank\">DNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272957-drillers-and-explorers-move-higher-alongside-oil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Drillers and explorers move higher alongside oil</a></h4><ul><li>Oil today is bouncing from near its lowest level of the year,&nbsp;<font color='green'>up 1%</font>&nbsp;to $46.30 per barrel.</li><li>It's giving a boost to a number of small-cap, exploration-related names. Among them: Denbury Resources (<a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='green'>+7.2%</font>), Eclipse Resources (<a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='green'>+7.3%</font>), Helix Energy (<a href='https://seekingalpha.com/symbol/HLX' title='Helix Energy Solutions Group, Inc.'>HLX</a> <font color='green'>+7.2%</font>), Cypress Energy (<a href='https://seekingalpha.com/symbol/CELP' title='Cypress Energy Partners, L.P.'>CELP</a> <font color='green'>+6%</font>), Diamond Offshore (<a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling Inc.'>DO</a> <font color='green'>+6.3%</font>), SAExploration (<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+7%</font>), W&amp;T Offshore (<a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='green'>+6.2%</font>), EP Energy (<a href='https://seekingalpha.com/symbol/EPE' title='EP Energy Corporation'>EPE</a> <font color='green'>+6.4%</font>), Sanchez Energy (<a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='green'>+5.6%</font>), Rowan (<a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a> <font color='green'>+6.3%</font>), USA Compression (<a href='https://seekingalpha.com/symbol/USAC' title='USA Compression Partners, LP'>USAC</a> <font color='green'>+6.9%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3272957\" data-linked=\"Drillers and explorers move higher alongside oil\" data-tweet=\"$DNR $DNR $ECR-OLD - Drillers and explorers move higher alongside oil https://seekingalpha.com/news/3272957-drillers-and-explorers-move-higher-alongside-oil?source=tweet\" data-url=\"https://seekingalpha.com/news/3272957-drillers-and-explorers-move-higher-alongside-oil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272953\" data-ts=\"1497284381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPG\" target=\"_blank\">SPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272953-big-day-for-retail-names-boosts-those-who-rent-space\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big day for retail names boosts those who rent them space</a></h4><ul><li>J.C. Penney, Kohl's, Urban Outfitters, Stein Mart, Citi Trends, Gap, L Brands, and Asecena Retail Group <a href=\"https://seekingalpha.com/news/3272919-chain-store-stocks-catch-bid\" target=\"_blank\">are among those leading</a> the retail sector into the green on a day when the major averages are all lower.</li><li>It's giving a lift to Simon Property (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='green'>+2.4%</font>), GGP (GGP <font color='green'>+2.4%</font>), Kimco (<a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='green'>+2.5%</font>), Weingarten (<a href='https://seekingalpha.com/symbol/WRI' title='Weingarten Realty Investors'>WRI</a> <font color='green'>+2.2%</font>), Federal Realty (<a href='https://seekingalpha.com/symbol/FRT' title='Federal Realty Investment Trust'>FRT</a> <font color='green'>+1.1%</font>), CBL &amp; Associates (<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='green'>+3.1%</font>), Regency Centers (<a href='https://seekingalpha.com/symbol/REG' title='Regency Centers Corporation'>REG</a> <font color='green'>+1.3%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3272953\" data-linked=\"Big day for retail names boosts those who rent them space\" data-tweet=\"$SPG $SPG $BPR - Big day for retail names boosts those who rent them space https://seekingalpha.com/news/3272953-big-day-for-retail-names-boosts-those-who-rent-space?source=tweet\" data-url=\"https://seekingalpha.com/news/3272953-big-day-for-retail-names-boosts-those-who-rent-space\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272938\" data-ts=\"1497283260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272938-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>    <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CYRX' title='CryoPort, Inc.'>CYRX</a> <font color='green'>+6%</font></li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TPB' title='Turning Point Brands'>TPB</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272938\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$CYRX $TPB $SORL - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3272938-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3272938-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272930\" data-ts=\"1497281345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272930-older-media-stocks-strong-in-face-of-tech-sell-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Older media stocks strong in face of tech sell-off</a></h4><ul>     <li>With tech selling off in what many tech investors see as an overdue breather, older-line media is having a moment today.</li>      <li>CBS (NYSE:<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>) is <font color='green'>up 2.3%</font> today amid word that it's gotten an <a href=\"https://seekingalpha.com/news/3272740-variety-cbs-cablers-start-early-upfront-ad-sales\" target=\"_blank\">early jump on its upfront ad sales</a>. Among other big broadcast nets: <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='green'>+0.6%</font>; <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+0.6%</font>; <a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='green'>+0.2%</font>.</li>     <li>Cable nets are having a good day as a group as well: AMC Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/AMCX' title='AMC Networks Inc.'>AMCX</a>) <font color='green'>up 2.1%</font>; Scripps Networks Interactive (NYSE:<a href='https://seekingalpha.com/symbol/SNI' title='Scripps Networks Interactive, Inc.'>SNI</a>) <font color='green'>up 1.5%</font>; Discovery Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/DISCA' title='Discovery Inc A'>DISCA</a>) +1.2%; Viacom (NASDAQ:<a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a>) <font color='green'>higher by 1.1%</font>.</li>     <li>And among news publishers: Scripps (NASDAQ:<a href='https://seekingalpha.com/symbol/SSP' title='The E.W. Scripps Company'>SSP</a>) is <font color='green'>up 2.2%</font>; Meredith (NYSE:<a href='https://seekingalpha.com/symbol/MDP' title='Meredith Corporation'>MDP</a>) <font color='green'>up 1.7%</font>; Gannett (NYSE:<a href='https://seekingalpha.com/symbol/GCI' title='Gannett Co., Inc.'>GCI</a>) <font color='green'>up 0.6%</font>. The New York Times Co. (NYSE:<a href='https://seekingalpha.com/symbol/NYT' title='New York Times Co.'>NYT</a>) is sitting out the rally for now, flat on the day.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3272740-variety-cbs-cablers-start-early-upfront-ad-sales\" target=\"_blank\">Variety: CBS, cablers start early upfront ad sales</a> (Jun. 09 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3272930\" data-linked=\"Older media stocks strong in face of tech sell-off\" data-tweet=\"$CBS $VIAC $DIS - Older media stocks strong in face of tech sell-off https://seekingalpha.com/news/3272930-older-media-stocks-strong-in-face-of-tech-sell-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3272930-older-media-stocks-strong-in-face-of-tech-sell-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272929\" data-ts=\"1497281025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDRM\" target=\"_blank\">NDRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272929-neuroderm-mulling-sale-shares-up-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeuroDerm mulling sale; shares up 12%</a></h4><ul><li>NeuroDerm (<a href='https://seekingalpha.com/symbol/NDRM' title='NeuroDerm'>NDRM</a> <font color='green'>+12%</font>) bucks the market's sour mood. Shares are up on a 50% spike in volume on rumors that it is exploring a possible sale.</li><li>The company is developing treatments for Parkinson's disease, including a continuous subcutaneously delivered formulation of levodopa/carbidopa.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3272929\" data-linked=\"NeuroDerm mulling sale; shares up 12%\" data-tweet=\"$NDRM - NeuroDerm mulling sale; shares up 12% https://seekingalpha.com/news/3272929-neuroderm-mulling-sale-shares-up-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3272929-neuroderm-mulling-sale-shares-up-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272926\" data-ts=\"1497280101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNMK\" target=\"_blank\">GNMK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272926-fda-clears-genmarks-eplex-system-and-rp-panel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears GenMark&#39;s ePlex system and RP Panel</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/16858634-genmark-receives-fda-510-k-market-clearance-eplex-instrument-respiratory-pathogen-panel\" target=\"_blank\">grants 510(k) clearance</a> for GenMark's (<a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a> <font color='green'>+0.6%</font>) ePlex instrument and Respiratory Pathogen &#40;RP&#41; Panel.</li><li>The ePlex system integrates nucleic acid extraction, amplification and detection into a fully automated device.</li><li>The PR panel detects over 20 viral and bacterial pathogens that cause upper respiratory infections.</li><li>The company says it has secured over 70 ePlex customer agreements totaling more than 100 analyzers. Q2 revenues should come in at $12M - 13M while 2016's top line should be $65M - 70M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272926\" data-linked=\"FDA clears GenMark&#39;s ePlex system and RP Panel\" data-tweet=\"$GNMK - FDA clears GenMark&#39;s ePlex system and RP Panel https://seekingalpha.com/news/3272926-fda-clears-genmarks-eplex-system-and-rp-panel?source=tweet\" data-url=\"https://seekingalpha.com/news/3272926-fda-clears-genmarks-eplex-system-and-rp-panel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272891\" data-ts=\"1497279680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272891-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='green'>+55%</font>. <a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/MLSS' title='Milestone Scientific Inc.'>MLSS</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/NDRM' title='NeuroDerm'>NDRM</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MYOV' title='Myovant Sciences'>MYOV</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272891\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$XBIT $ONCT $MLSS - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3272891-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3272891-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272924\" data-ts=\"1497279665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272924-sinclair-cbs-extend-affiliation-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair, CBS extend affiliation deal</a></h4><ul>   <li>Sinclair Broadcast Group (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color='green'>+0.7%</font>) is <a href=\"http://deadline.com/2017/06/sinclair-renews-cbs-affiliate-deals-four-markets-vow-add-tribune-1202111591/\" target=\"_blank\">extending its affiliation agreement</a> with CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='green'>+3.3%</font>), adding on to deals in Salt Lake City; Austin, Texas; South Bend, Ind.; and Gainesville, Fla.</li>    <li>The multi-year deal extension would cover Tribune Media's (<a href=\"http://seekingalpha.com/symbol/TRCO\" target=\"_blank\">TRCO</a> <font color='green'>+0.4%</font>) six CBS stations if Sinclair can complete its $3.9B buyout, Sinclair says.</li>    <li>It also paves the way for local content to be available via the CBS All Access app.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3272924\" data-linked=\"Sinclair, CBS extend affiliation deal\" data-tweet=\"$SBGI $SBGI $VIAC - Sinclair, CBS extend affiliation deal https://seekingalpha.com/news/3272924-sinclair-cbs-extend-affiliation-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3272924-sinclair-cbs-extend-affiliation-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272920\" data-ts=\"1497279110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272920-selloff-banks-continue-to-run-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Selloff? Banks continue to run higher</a></h4><ul><li>The major averages are in the red, particularly the Nasdaq,<font color='red'> down 0.75%</font>. The broad banking sector (<a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a>, <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a>) is<font color='green'> up another 1%</font>&nbsp;though, and&nbsp;<font color='green'>nearly 7%&nbsp;</font>since last Monday.</li><li>A Fed rate hike is in the cards later this week which should help boost profits for lenders, but the yield curve - already flat - will be getting even more so. And don't flat yield curves tend to presage recessions?</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>, <a href='https://seekingalpha.com/symbol/FAS' title='Direxion Daily Financial Bull 3x Shares ETF'>FAS</a>, <a href='https://seekingalpha.com/symbol/FAZ' title='Direxion Daily Financial Bear 3x Shares ETF'>FAZ</a>, <a href='https://seekingalpha.com/symbol/VFH' title='Vanguard Financials ETF'>VFH</a>, <a href='https://seekingalpha.com/symbol/UYG' title='ProShares Ultra Financials ETF'>UYG</a>, <a href='https://seekingalpha.com/symbol/IYF' title='iShares U.S. Financials ETF'>IYF</a>, <a href='https://seekingalpha.com/symbol/FNCL' title='Fidelity MSCI Financials Index ETF'>FNCL</a>, <a href='https://seekingalpha.com/symbol/BTO' title='John Hancock Financial Opportunity Fund'>BTO</a>, <a href='https://seekingalpha.com/symbol/IYG' title='iShares U.S. Financial Services ETF'>IYG</a>, <a href='https://seekingalpha.com/symbol/FXO' title='First Trust Financials AlphaDEX ETF'>FXO</a>, <a href='https://seekingalpha.com/symbol/SEF' title='ProShares Short Financials ETF'>SEF</a>, <a href='https://seekingalpha.com/symbol/RYF' title='Guggenheim S&P Equal Weight Financial ETF'>RYF</a>, <a href='https://seekingalpha.com/symbol/FINU' title='ProShares UltraPro Financials ETF'>FINU</a>, <a href='https://seekingalpha.com/symbol/XLFS' title='Financial Services Select Sector SPDR ETF'>XLFS</a>, <a href='https://seekingalpha.com/symbol/FINZ' title='ProShares UltraPro Short Financials ETF'>FINZ</a>, <a href='https://seekingalpha.com/symbol/RWW' title='Oppenheimer Financials Sector Revenue ETF'>RWW</a>, <a href='https://seekingalpha.com/symbol/FAZZ' title='Direxion Daily Financial Bear 1x Shares ETF'>FAZZ</a>, <a href='https://seekingalpha.com/symbol/JHMF' title='John Hancock Multifactor Financials ETF'>JHMF</a>, <a href='https://seekingalpha.com/symbol/FNCF' title='iShares Edge MSCI Multifactor Financials ETF'>FNCF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3272920\" data-linked=\"Selloff? Banks continue to run higher\" data-tweet=\"$KRE $KBE $XLF - Selloff? Banks continue to run higher https://seekingalpha.com/news/3272920-selloff-banks-continue-to-run-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3272920-selloff-banks-continue-to-run-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272919\" data-ts=\"1497278808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272919-chain-store-stocks-catch-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chain store stocks catch a bid</a></h4><ul> <li>Retail stocks are outpacing the broad market once again, led by the beat-up chain store sector.</li> <li>The efforts by the Nordstrom family to take the company private and some tamping down of border tax concerns continue to give investors some reasons to be constructive on the sector.</li> <li>Notable gainers include J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='green'>+4.9%</font>), Kohl's (<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a> <font color='green'>+2.5%</font>), Urban Outfitters (<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a> <font color='green'>+3.4%</font>), Stein Mart (<a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a> <font color='green'>+9.2%</font>), Citi Trends (<a href='https://seekingalpha.com/symbol/CTRN' title='Citi Trends, Inc.'>CTRN</a> <font color='green'>+3.6%</font>), Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='green'>+2%</font>), L Brands (<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='green'>+4.1%</font>) and Ascena Retail Group (<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='green'>+7.3%</font>).</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3272766-retail-sector-looks-shake-border-tax-talk\" target=\"_blank\">Retail sector looks to shake off border tax talk</a> (June 10)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3272919\" data-linked=\"Chain store stocks catch a bid\" data-tweet=\"$JCP $JCP $KSS - Chain store stocks catch a bid https://seekingalpha.com/news/3272919-chain-store-stocks-catch-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3272919-chain-store-stocks-catch-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272912\" data-ts=\"1497277858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDG\" target=\"_blank\">TDG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272912-transdigm-on-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransDigm on the move</a></h4><ul><li>TransDigm (NYSE:<a href='https://seekingalpha.com/symbol/TDG' title='TransDigm Group Incorporated'>TDG</a>) starts the week <font color='red'>down 6.2%</font> on reports that Senator Elizabeh Warren sent a letter in May regarding her request for an investigation of the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272912\" data-linked=\"TransDigm on the move\" data-tweet=\"$TDG - TransDigm on the move https://seekingalpha.com/news/3272912-transdigm-on-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3272912-transdigm-on-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272910\" data-ts=\"1497277657\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKT\" target=\"_blank\">SKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272910-citi-pulls-sell-recommendation-on-tanger-factory-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi pulls sell recommendation on Tanger Factory; shares up more than 2%</a></h4><ul><li>Tanger Factory (NYSE:<a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a>) is<font color='red'> lower by nearly 30%</font>&nbsp;amid the meltdown for retail landlords this year. Citi rings the register on its Sell rating, <a href=\"https://www.streetinsider.com/Upgrades/Citi+Upgrades+Tanger+Factory+Outlet+Centers+%28SKT%29+to+Neutral/13001576.html\" target=\"_blank\">upgrading to Neutral</a>.</li><li>SKT<font color='green'> up 2.6%</font>&nbsp;on today's session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272910\" data-linked=\"Citi pulls sell recommendation on Tanger Factory; shares up more than 2%\" data-tweet=\"$SKT - Citi pulls sell recommendation on Tanger Factory; shares up more than 2% https://seekingalpha.com/news/3272910-citi-pulls-sell-recommendation-on-tanger-factory-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3272910-citi-pulls-sell-recommendation-on-tanger-factory-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272907\" data-ts=\"1497277197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272907-piper-jaffray-raises-amazon-price-target-shares-down-2_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray raises Amazon price target; shares down 2.4%</a></h4><ul><li>        Piper Jaffray <a href=\"http://www.cnbc.com/2017/06/12/what-sell-off-amazon-gets-1200-price-forecast-from-analyst.html\" target=\"_blank\">reiterates</a> the Overweight rating on Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) but pushes price target up $150 to $1,200.</li><li>               Analyst Michael Olson writes that the firm&rsquo;s proprietary Google search trend analysis indicates Amazon&rsquo;s retail growth is unlikely to decelerate in Q2.&nbsp;</li><li>               Olson noted that the search analysis showed that Amazon-related words had a 23% year-over-year growth in June, which matched the growth amount in March.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='red'>down 2.38%</font>.&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3272907\" data-linked=\"Piper Jaffray raises Amazon price target; shares down 2.4%\" data-tweet=\"$AMZN - Piper Jaffray raises Amazon price target; shares down 2.4% https://seekingalpha.com/news/3272907-piper-jaffray-raises-amazon-price-target-shares-down-2_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3272907-piper-jaffray-raises-amazon-price-target-shares-down-2_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272905\" data-ts=\"1497276963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMT\" target=\"_blank\">AMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272905-tower-reits-drop-raymond-james-tempers-enthusiasm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tower REITs drop as Raymond James tempers enthusiasm</a></h4><ul>   <li>Cell tower REITs are lower this morning after Raymond James backed off a bit from heavy bullishness, noting that some earlier optimism has showed up in strong stock performance.</li>    <li>The firm has downgraded American Tower (<a href=\"http://seekingalpha.com/symbol/AMT\" target=\"_blank\">AMT</a> <font color='red'>-1.9%</font>) and SBA Communications (<a href=\"http://seekingalpha.com/symbol/SBAC\" target=\"_blank\">SBAC</a> <font color='red'>-2.1%</font>) to Outperform, from Strong Buy. It also went to Market Perform from Outperform on Crown Castle International (<a href=\"http://seekingalpha.com/symbol/CCI\" target=\"_blank\">CCI</a> <font color='red'>-0.6%</font>).</li>    <li>Crown Castle is <font color='green'>up 16.8%</font> YTD; <a href='https://seekingalpha.com/symbol/AMT' title='American Tower Corporation'>AMT</a> is <font color='green'>up 21.6%</font> in that time frame and <a href='https://seekingalpha.com/symbol/SBAC' title='SBA Communications Corporation'>SBAC</a> <font color='green'>up 27.2%</font>.</li>    <li>While Raymond James' Ric Prentiss is still long-term bullish, with sector activity increasing amid heavy appetites for mobile data, he wouldn't be surprised if the next catalyst comes via negatives from a Sprint/T-Mobile deal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3272905\" data-linked=\"Tower REITs drop as Raymond James tempers enthusiasm\" data-tweet=\"$AMT $AMT $SBAC - Tower REITs drop as Raymond James tempers enthusiasm https://seekingalpha.com/news/3272905-tower-reits-drop-raymond-james-tempers-enthusiasm?source=tweet\" data-url=\"https://seekingalpha.com/news/3272905-tower-reits-drop-raymond-james-tempers-enthusiasm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272904\" data-ts=\"1497276834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGC\" target=\"_blank\">RGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272904-bear-call-from-moffettnathanson-on-theater-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bear call from MoffettNathanson on theater stocks</a></h4><ul> <li>MoffettNathanson Research says it can no longer ignore the dual concerns of Netflix and premium video on-demand on the exhibitor sector.</li> <li>\"While each of these threats is unlikely to pose a material negative impact to near-term financials, we expect these longer-term industry headwinds to pressure the multiple investors use to value exhibition stocks,\" writes Robert Fishman.</li>  <li>The boutique firm cuts Regal Entertainment (<a href='https://seekingalpha.com/symbol/RGC' title='Regal Entertainment Group'>RGC</a> <font color='green'>+0.7%</font>) to Sell and lowers the price target of $17.</li> <li>Cinemark (<a href='https://seekingalpha.com/symbol/CNK' title='Cinemark Holdings, Inc'>CNK</a> <font color='red'>-0.4%</font>) also goes to Sell at MoffettNathanson and sees a price target drop to $33.</li> <li>Sector peek: AMC Entertainment (<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a> <font color='green'>+1.7%</font>) and IMAX (<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a> <font color='green'>+1%</font>) are having a strong day, but are both down over 20% YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272904\" data-linked=\"Bear call from MoffettNathanson on theater stocks\" data-tweet=\"$RGC $RGC $CNK - Bear call from MoffettNathanson on theater stocks https://seekingalpha.com/news/3272904-bear-call-from-moffettnathanson-on-theater-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3272904-bear-call-from-moffettnathanson-on-theater-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272903\" data-ts=\"1497276626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SO\" target=\"_blank\">SO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272903-toshiba-commits-3_68b-to-finish-southerns-georgia-nuclear-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toshiba commits $3.68B to finish Southern&#39;s Georgia nuclear plant</a></h4><ul>     <li>Southern Co. (<a href='https://seekingalpha.com/symbol/SO' title='Southern Company'>SO</a> <font color='green'>+1%</font>) opens higher, as a deal with Toshiba's (<a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a> <font color='green'>+9.1%</font>) Westinghouse subsidiary for <a href=\"https://seekingalpha.com/news/3272772-wdc-raise-toshiba-chip-offer\" target=\"_blank\">completion of the half-constructed Vogtle nuclear power plant</a> in Georgia lifts some of the uncertainty over the fate of the project.</li>     <li>Toshiba agrees to pay $3.68B to SO to help cover the costs of completing two reactors at the plant, while SO agrees not to ask for more, even if the project continues to run over budget.</li>     <li>SCANA (<a href='https://seekingalpha.com/symbol/SCG' title='SCANA Corporation'>SCG</a> <font color='green'>+1.2%</font>) shares also are higher, as the deal could <a href=\"http://www.aikenstandard.com/news/savannah-river-site/editorial-vogtle-deal-relieves-some-uncertainty/article_b6d471c4-4ed9-11e7-8e98-2fd0c2be3880.html\" target=\"_blank\">foreshadow</a> how things will play out at the V.C. Summer plant in South Carolina, where Westinghouse also is the lead contractor.</li>     <li>Despite the agreement, it is not clear&nbsp;if the Vogtle facility will be completed; last week, a consultant to the Georgia Public Service Commission filed a report saying that,&nbsp;under several scenarios, it was &ldquo;<a href=\"https://www.wsj.com/articles/toshiba-southern-reach-deal-on-troubled-u-s-nuclear-plant-1497067866\" target=\"_blank\">not economic</a>&rdquo; to continue work on the project.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272903\" data-linked=\"Toshiba commits $3.68B to finish Southern&#39;s Georgia nuclear plant\" data-tweet=\"$SO $SO $TOSYY - Toshiba commits $3.68B to finish Southern&#39;s Georgia nuclear plant https://seekingalpha.com/news/3272903-toshiba-commits-3_68b-to-finish-southerns-georgia-nuclear-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/3272903-toshiba-commits-3_68b-to-finish-southerns-georgia-nuclear-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272902\" data-ts=\"1497276607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272902-goldman-sachs-reiterates-amd-sell-rating-shares-down-3_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs reiterates AMD Sell rating; shares down 3.4%</a></h4><ul><li>        Goldman Sachs reiterates Sell rating and $10.60 price target on Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) after last week&rsquo;s 13% gains on the news that cryptocurrency miners were causing the company to sell out of graphics cards.</li><li>               Analyst Toshiya Hari writes that cryptocurrency interest doesn&rsquo;t always lead to higher shipments and does not see this specialized demand driving EPS, desktop market share, or ASP expansion in any sustainable way.&nbsp;</li><li>                  Hari prefers Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>)&nbsp;for gaming, VR, and data center growth exposure. </li><li>Source: Bloomberg</li><li>AMD shares are&nbsp;<font color='red'>down 3.38%</font>. &nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3271860-amd-shares-6_6-percent-cryptocurrency-demands-imac-inclusion\" target=\"_blank\">AMD shares up 6.6% on cryptocurrency demands, iMac inclusion</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3272902\" data-linked=\"Goldman Sachs reiterates AMD Sell rating; shares down 3.4%\" data-tweet=\"$AMD $AMD $NVDA - Goldman Sachs reiterates AMD Sell rating; shares down 3.4% https://seekingalpha.com/news/3272902-goldman-sachs-reiterates-amd-sell-rating-shares-down-3_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3272902-goldman-sachs-reiterates-amd-sell-rating-shares-down-3_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>140&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272898\" data-ts=\"1497276173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272898-netflix-and-altice-ink-10-market-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix and Altice ink 10-market deal</a></h4><ul> <li>Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='red'>-4.3%</font>) signs a multi-year <a href=\"https://seekingalpha.com/news/3249809-altice-mum-possible-u-s-listing\" target=\"_blank\">deal</a> with Altice (<a href='https://seekingalpha.com/symbol/ATCEY' title='ALTICE S A ADR'>OTCPK:ATCEY</a>) covering 10 markets.</li> <li>While the content deal includes France, Portugal, Israel and the Dominican Republic, the U.S is not covered. That's not a complete surprise with Altice USA believed to be <a href=\"https://seekingalpha.com/news/3249809-altice-mum-possible-u-s-listing\" target=\"_blank\">mulling over</a> an IPO.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3272898\" data-linked=\"Netflix and Altice ink 10-market deal\" data-tweet=\"$NFLX $NFLX $ATCEY - Netflix and Altice ink 10-market deal https://seekingalpha.com/news/3272898-netflix-and-altice-ink-10-market-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3272898-netflix-and-altice-ink-10-market-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272896\" data-ts=\"1497275620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272896-mizuho-securities-downgrades-apple-shares-down-nearly-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mizuho Securities downgrades Apple; shares down nearly 4%</a></h4><ul><li>        Mizuho Securities <a href=\"http://www.reuters.com/article/us-apple-stocks-idUSKBN1931HF?feedType=RSS&amp;feedName=businessNews&amp;utm_source=Twitter&amp;utm_medium=Social&amp;utm_campaign=Feed%3A+reuters%2FbusinessNews+%28Business+News%29\" target=\"_blank\">downgrades</a> Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) from Buy to Neutral and knocks the price target down $10 to $150.</li><li>               Analyst Abhet Lamba writes that the current levels already have this year&rsquo;s growth and the upcoming iPhone enthusiasm baked into the price. Lamba expects limited upside to estimates in the near future.&nbsp;</li><li>               The downgrade follows last week&rsquo;s Pacific Crest Securities downgrade and Bloomberg&rsquo;s report that the new iPhone models might have slower speeds due to modem supply issues. Apple was also part of the great tech pullback on Friday.&nbsp;</li><li>               Apple shares are&nbsp;<font color='red'>down 3.97%</font>.&nbsp;&nbsp; &nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3272896\" data-linked=\"Mizuho Securities downgrades Apple; shares down nearly 4%\" data-tweet=\"$AAPL - Mizuho Securities downgrades Apple; shares down nearly 4% https://seekingalpha.com/news/3272896-mizuho-securities-downgrades-apple-shares-down-nearly-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3272896-mizuho-securities-downgrades-apple-shares-down-nearly-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272895\" data-ts=\"1497275597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272895-rite-aid-and-freds-look-to-recover\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rite Aid and Fred&#39;s look to recover</a></h4><ul> <li>Shares of Rite Aid (<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color='green'>+0.7%</font>) and Fred's (<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='green'>+2.7%</font>) are taking back some ground lost on Friday after Captial Forum reported that the FTC is prepping to block the Rite Aid-Walgreens merger.</li> <li>Earlier this morning, Fred's disclosed that it increased the available financing at its disposal for the planned purchase of 850 Rite Aid stores.</li> <li><a href=\"https://seekingalpha.com/filing/3590066\" target=\"_blank\">Fred's SEC form 8-K</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3272895\" data-linked=\"Rite Aid and Fred&#39;s look to recover\" data-tweet=\"$RAD $RAD $FRED - Rite Aid and Fred&#39;s look to recover https://seekingalpha.com/news/3272895-rite-aid-and-freds-look-to-recover?source=tweet\" data-url=\"https://seekingalpha.com/news/3272895-rite-aid-and-freds-look-to-recover\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272887\" data-ts=\"1497274642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272887-celgene-teams-up-dragonfly-therapeutics-to-develop-immuno-oncology-treatments-for-blood\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene teams up with Dragonfly Therapeutics to develop immuno-oncology treatments for blood cancers</a></h4><ul><li>Privately held <a href=\"http://dragonflytx.com/\" target=\"_blank\">Dragonfly Therapeutics</a> enters into a <a href=\"https://seekingalpha.com/pr/16858850-dragonfly-therapeutics-announces-strategic-collaboration-celgene-discover-develop-novel\" target=\"_blank\">global collaboration</a> with Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+0.9%</font>) to develop and commercialize immuno-oncology therapeutics for patients with blood cancers based on Dragnonfly's Natural Killer cell-based <a href=\"http://dragonflytx.com/technology\" target=\"_blank\">TriNKET platform</a>.</li><li>Under the terms for the agreement, Dragonfly will receive an upfront payment of $33M, milestones and royalties on net sales. Celgene will have the exclusive option to in-license up to four candidates for the treatment of acute myeloid leukemia, multiple myeloma and additional blood cancers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272887\" data-linked=\"Celgene teams up with Dragonfly Therapeutics to develop immuno-oncology treatments for blood cancers\" data-tweet=\"$CELG - Celgene teams up with Dragonfly Therapeutics to develop immuno-oncology treatments for blood cancers https://seekingalpha.com/news/3272887-celgene-teams-up-dragonfly-therapeutics-to-develop-immuno-oncology-treatments-for-blood?source=tweet\" data-url=\"https://seekingalpha.com/news/3272887-celgene-teams-up-dragonfly-therapeutics-to-develop-immuno-oncology-treatments-for-blood\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272885\" data-ts=\"1497274125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272885-wecast-lands-51-stake-in-nextgen-exchange-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wecast lands 51% stake in NextGen Exchange Group</a></h4><ul>     <li>Wecast Network (WCST) announces that it acquired a 51% stake of NextGen Exchange Group.</li>     <li>The company says the blockchain index exchange will reside and operate under its Wecast Services Group and become an essential component of Wecast's Transactional Finance Product Cloud business.</li>     <li>WCST will purchase 51% of the outstanding capital shares in NextGen Exchange Group from Redrock Capital Group Limited and enter a separate agreement with the Delaware Board Of Trade Holdings to transfer 5% of the stock of NextGen to Delaware Board of Trade Holdings.</li>          <li>WCST&nbsp;<font color='green'>+12.55%</font>&nbsp;premarket to $2.60.</li>          <li>Source: <a href=\"https://seekingalpha.com/pr/16858853-wecast-purchase-51-percent-nextgen-exchange-group\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3272885\" data-linked=\"Wecast lands 51% stake in NextGen Exchange Group\" data-tweet=\"$SSC-OLD - Wecast lands 51% stake in NextGen Exchange Group https://seekingalpha.com/news/3272885-wecast-lands-51-stake-in-nextgen-exchange-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3272885-wecast-lands-51-stake-in-nextgen-exchange-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272883\" data-ts=\"1497274080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSBK\" target=\"_blank\">FSBK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272883-carolina-financial-buying-first-south-bancorp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carolina Financial buying First South Bancorp</a></h4><ul><li>HQ'd in Washington, NC, First South (NASDAQ:<a href='https://seekingalpha.com/symbol/FSBK' title='First South Bancorp Inc'>FSBK</a>) has assets of about $1B, loans of $730M, and deposits of $920M.</li><li>The combined lender will have $3.2B in assets, $2.2B in loans, and $2.5B of deposits.</li><li>First South owners will receive 0.52 shares of Carolina Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/CARO' title='Carolina Financial Corp'>CARO</a>) common stock for each share of FSBK they hold. It's a deal value of $162M based on Friday's close, or $16.89 per FSBK share - a&nbsp;<font color='green'>16.4% premium</font>&nbsp;to Friday's close.</li><li>A <a href=\"http://www.haveanicebank.com\" target=\"_blank\">conference call </a>is set for 11 ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272883\" data-linked=\"Carolina Financial buying First South Bancorp\" data-tweet=\"$FSBK $FSBK $CARO - Carolina Financial buying First South Bancorp https://seekingalpha.com/news/3272883-carolina-financial-buying-first-south-bancorp?source=tweet\" data-url=\"https://seekingalpha.com/news/3272883-carolina-financial-buying-first-south-bancorp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272882\" data-ts=\"1497273849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RWLK\" target=\"_blank\">RWLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272882-bsbc-of-florida-to-cover-rewalk-exoskeleton-for-spinal-cord-injury-patients-shares-up-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BSBC of Florida to cover Rewalk exoskeleton for spinal cord injury patients; shares up 11% premarket</a></h4><ul><li>Thinly traded nano cap Rewalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a>) perks up&nbsp;<font color='green'>11%</font>&nbsp;premarket on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/16858669-florida-blue-cross-blue-shield-cover-rewalk-exoskeleton-paralyzed-plan-member-following-court\" target=\"_blank\">announcement </a>that a Florida court has ordered Blue Cross Blue Shield of Florida to cover the <a href=\"http://rewalk.com/rewalk-personal-3/\" target=\"_blank\">ReWalk exoskeleton</a> for plan members with a spinal cord injury.</li><li>CEO Larry Jasinski&nbsp;says, \"The recent&nbsp;Florida&nbsp;ruling is significant and consistent with the growing body of established scientific data that supports the value of exoskeletal walking. &nbsp;We are encouraged by the chorus of experts who are supporting paralyzed individuals in their appeals processes, and heartened by the trend of coverage rulings that continues to increase in states across the U.S.&nbsp; It is our fervent hope that insurance companies will stop this arduous process of appeals and formulate standard operating policies for coverage of all eligible SCI plan members.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3272882\" data-linked=\"BSBC of Florida to cover Rewalk exoskeleton for spinal cord injury patients; shares up 11% premarket\" data-tweet=\"$RWLK - BSBC of Florida to cover Rewalk exoskeleton for spinal cord injury patients; shares up 11% premarket https://seekingalpha.com/news/3272882-bsbc-of-florida-to-cover-rewalk-exoskeleton-for-spinal-cord-injury-patients-shares-up-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3272882-bsbc-of-florida-to-cover-rewalk-exoskeleton-for-spinal-cord-injury-patients-shares-up-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272880\" data-ts=\"1497273514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCUL\" target=\"_blank\">OCUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272880-ocular-medical-chief-bids-adieu-shares-down-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocular medical chief bids adieu; shares down 5% premarket</a></h4><ul><li>Ocular Therapeutix (NASDAQ:<a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a>) slips&nbsp;<font color='red'>5%</font>&nbsp;premarket on light volume on the heel of its <a href=\"https://seekingalpha.com/filing/3589264\" target=\"_blank\">announcement </a>that Chief Medical Officer Jonathan Talamo will resign effective June 15. No reasons are given for his departure.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272880\" data-linked=\"Ocular medical chief bids adieu; shares down 5% premarket\" data-tweet=\"$OCUL - Ocular medical chief bids adieu; shares down 5% premarket https://seekingalpha.com/news/3272880-ocular-medical-chief-bids-adieu-shares-down-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3272880-ocular-medical-chief-bids-adieu-shares-down-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272879\" data-ts=\"1497273482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272879-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='green'>+17%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a> <font color='green'>+12%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a>&nbsp;<font color='green'>+12%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3272826-gtxs-enobosarm-shows-treatment-effect-mid-stage-study-postmenopausal-women-stress-urinary\" target=\"_blank\">announcement</a><a href=\"https://seekingalpha.com/news/3272826-gtxs-enobosarm-shows-treatment-effect-mid-stage-study-postmenopausal-women-stress-urinary\" target=\"_blank\">&nbsp;</a>of positive interim results from a&nbsp;Phase 2 proof-of-concept study&nbsp;assessing enobosarm (GTx-024) for the treatment of postmenopausal women with stress urinary incontinence.</li>     <li><a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='green'>+11%</font>&nbsp;ON <a href=\"https://seekingalpha.com/pr/16858669-florida-blue-cross-blue-shield-cover-rewalk-exoskeleton-paralyzed-plan-member-following-court\" target=\"_blank\">announcement </a>that a&nbsp;Florida&nbsp;court ruling that found Blue Cross Blue Shield of Florida must provide coverage of a ReWalk exoskeleton system for a plan member with a spinal cord injury.</li>     <li><a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3272879\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$XBIT $QIWI $ONCT - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3272879-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3272879-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272873\" data-ts=\"1497273012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272873-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a>&nbsp;<font color='red'>-30%</font>&nbsp;on FDA <a href=\"https://seekingalpha.com/news/3272814-fda-rejects-coherus-marketing-application-neulasta-biosimilar-shares-34-percent-premarket\" target=\"_blank\">rejecting</a> marketing application for Neulasta biosimilar.</li><li><a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a>&nbsp;<font color='red'>-29%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3272815-regulus-bails-hcv-candidate-rgminus-101-shares-35-percent-premarket\" target=\"_blank\">announcing</a> discontinuation of HCV candidate RG-101.</li><li><a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3272873\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$CHRS $RGLS $ICHR - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3272873-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3272873-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272863\" data-ts=\"1497272029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIT\" target=\"_blank\">WIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272863-wipro-shares-down-48-amidst-growth-concerns-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wipro shares down 48% amidst growth concerns, downgrades</a></h4><ul><li>        Wipro Limited (NYSE:<a href='https://seekingalpha.com/symbol/WIT' title='Wipro Limited'>WIT</a>) shares are plummeting premarket potentially due to some revelations last week that might have dampened investor confidence.</li><li>        Last week, Wipro <a href=\"https://seekingalpha.com/filing/3579333\" target=\"_blank\">released</a> the 20-F report that included the disclosure that the U.S. election and President Trump could harm the company&rsquo;s future growth due to Trump&rsquo;s campaign stances on trade and NAFTA.</li><li>               Jefferies <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Jefferies+Downgrades+Wipro+Ltd.+%28WIT%29+to+Underperform/12985967.html\" target=\"_blank\">downgraded</a> Wipro from Hold to Underperform last week due to weak performance and low visibility on both revenue and margin with no change expected soon.&nbsp;</li><li>               Current analyst standings for Wipro include 5 Buy, 4 Outperform, 19 Hold, 16 Underperform, and 4 Sell.&nbsp;</li><li>Wipro shares&nbsp;<font color='red'>down 48.04%&nbsp;</font>premarket. &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3272863\" data-linked=\"Wipro shares down 48% amidst growth concerns, downgrades\" data-tweet=\"$WIT - Wipro shares down 48% amidst growth concerns, downgrades https://seekingalpha.com/news/3272863-wipro-shares-down-48-amidst-growth-concerns-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3272863-wipro-shares-down-48-amidst-growth-concerns-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272856\" data-ts=\"1497271588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCSC\" target=\"_blank\">FCSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272856-fibrocells-gene-therapy-candidate-fcxminus-013-nabs-rare-pediatric-disease-designation-from\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fibrocell&#39;s gene therapy candidate FCX-013 nabs Rare Pediatric Disease Designation from FDA; shares ahead 9% premarket</a></h4><ul><li>Thinly traded nano cap Fibrocell Science (NASDAQ:<a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a>) perks up&nbsp;<font color='green'>9%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16858588-fibrocell-receives-rare-pediatric-disease-designation-fda-fcxminus-013-treatment-localized\" target=\"_blank\">announcement </a>that the FDA has granted Rare Pediatric Disease Designation to Orphan Drug-tagged FCX-013, a gene therapy candidate for the treatment of moderate-to-severe localized scleroderma.</li><li>The designation, the company's second, makes the company eligible to receive a Rare Pediatric Disease Priority Review Voucher after the product is approved. The voucher can be used for accelerated approval of a future product or it can be transferred or sold.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272856\" data-linked=\"Fibrocell&#39;s gene therapy candidate FCX-013 nabs Rare Pediatric Disease Designation from FDA; shares ahead 9% premarket\" data-tweet=\"$FCSC - Fibrocell&#39;s gene therapy candidate FCX-013 nabs Rare Pediatric Disease Designation from FDA; shares ahead 9% premarket https://seekingalpha.com/news/3272856-fibrocells-gene-therapy-candidate-fcxminus-013-nabs-rare-pediatric-disease-designation-from?source=tweet\" data-url=\"https://seekingalpha.com/news/3272856-fibrocells-gene-therapy-candidate-fcxminus-013-nabs-rare-pediatric-disease-designation-from\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272842\" data-ts=\"1497270727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MELI\" target=\"_blank\">MELI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272842-mercadolibre-gets-call-up-to-nasdaq-100\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MercadoLibre gets call-up to Nasdaq 100</a></h4><ul> <li>MercadoLibre (NASDAQ:<a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a>) will replace Yahoo in the NASDAQ-100 Index and the NASDAQ-100 Equal Weighted Index on June 19.</li> <li><a href=\"http://www.nasdaqomx.com/newsroom/pressreleases/pressrelease?messageId=1582314&amp;displayLanguage=en\" target=\"_blank\">Nasdaq press release</a></li><li>MELI&nbsp;<font color='green'>+1.95%</font>&nbsp;premarket to $280.01.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3272842\" data-linked=\"MercadoLibre gets call-up to Nasdaq 100\" data-tweet=\"$MELI - MercadoLibre gets call-up to Nasdaq 100 https://seekingalpha.com/news/3272842-mercadolibre-gets-call-up-to-nasdaq-100?source=tweet\" data-url=\"https://seekingalpha.com/news/3272842-mercadolibre-gets-call-up-to-nasdaq-100\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272834\" data-ts=\"1497270317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOP\" target=\"_blank\">APOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272834-cellect-bio-nabs-u-s-patent-covering-apograft-shares-ahead-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellect Bio nabs U.S. patent covering ApoGraft, shares ahead 8% premarket</a></h4><ul><li>Thinly traded nano cap Cellect Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a>) is up&nbsp;<font color='green'>8%</font>&nbsp;premarket on light volume in response to its &nbsp;<a href=\"https://seekingalpha.com/pr/16858484-cellect-receives-notice-allowance-us-patent-and-trademark-office\" target=\"_blank\">announcement </a>that is has received a formal notice of allowance from the USPTO regarding its patent application covering a key composition of matter and method of use for its flagship technology, ApoGraft. The patent will cover any device that uses ApoGraft for the selection of stem cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272834\" data-linked=\"Cellect Bio nabs U.S. patent covering ApoGraft, shares ahead 8% premarket\" data-tweet=\"$APOP - Cellect Bio nabs U.S. patent covering ApoGraft, shares ahead 8% premarket https://seekingalpha.com/news/3272834-cellect-bio-nabs-u-s-patent-covering-apograft-shares-ahead-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3272834-cellect-bio-nabs-u-s-patent-covering-apograft-shares-ahead-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272830\" data-ts=\"1497269611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272830-trovagene-inks-deal-astrazeneca-for-urine-ctdna-test-and-services-shares-ahead-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trovagene inks deal with AstraZeneca for urine ctDNA test and services; shares ahead 10% premarket</a></h4><ul><li>Thinly traded nano cap Trovagene (NASDAQ:<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16858552-trovagene-enters-agreement-astrazeneca-utilize-trovera-ctdna-test-services-prospective\" target=\"_blank\">announcement </a>of an agreement with AstraZeneca under which it will provide its Trovera urine ctDNA biomarker test and services.</li><li>The Trovera EGFR urine liquid biopsy test will be initially evaluated in an open-label prospective study to determine if non-invasive testing (urine and blood) is as effective as tissue testing in identifying epidermal growth factor receptor &#40;EGFR&#41; T790M mutation status.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272830\" data-linked=\"Trovagene inks deal with AstraZeneca for urine ctDNA test and services; shares ahead 10% premarket\" data-tweet=\"$TROV - Trovagene inks deal with AstraZeneca for urine ctDNA test and services; shares ahead 10% premarket https://seekingalpha.com/news/3272830-trovagene-inks-deal-astrazeneca-for-urine-ctdna-test-and-services-shares-ahead-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3272830-trovagene-inks-deal-astrazeneca-for-urine-ctdna-test-and-services-shares-ahead-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272827\" data-ts=\"1497269375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272827-pivotal-research-downgrades-adobe-to-sell-shares-down-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pivotal Research downgrades Adobe to Sell; shares down 2% premarket</a></h4><ul><li>        Pivotal Research downgrades Adobe Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) with analyst Brian Wieser saying shares are &ldquo;up too much, too fast&rdquo; despite strong fundamentals.</li><li>               Wieser compares the year-to-date growths of Adobe and some tech competitors: Adobe: 34%; Facebook: 30%; Salesforce: 27%; Alphabet: 23%.&nbsp;</li><li>               Pivotal Research becomes the only Sell recommendation among 33 analysts with 26 Bu and 6 Hold rounding out the numbers. Average price target is $146.&nbsp;</li><li>               Adobe shares are&nbsp;<font color='red'>down 2.14%</font>&nbsp;premarket.&nbsp;</li><li>               Source: Bloomberg&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3272827\" data-linked=\"Pivotal Research downgrades Adobe to Sell; shares down 2% premarket\" data-tweet=\"$ADBE - Pivotal Research downgrades Adobe to Sell; shares down 2% premarket https://seekingalpha.com/news/3272827-pivotal-research-downgrades-adobe-to-sell-shares-down-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3272827-pivotal-research-downgrades-adobe-to-sell-shares-down-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272826\" data-ts=\"1497269025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTXI\" target=\"_blank\">GTXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272826-gtxs-enobosarm-shows-treatment-effect-in-mid-stage-study-in-postmenopausal-women-stress\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GTx&#39;s enobosarm shows treatment effect in mid-stage study in postmenopausal women with stress urinary incontinence; shares up 14% premarket</a></h4><ul><li>Thinly traded nano cap GTx (NASDAQ:<a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a>) jumps&nbsp;<font color='green'>14%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16858437-gtx-announces-positive-preliminary-results-ongoing-phase-2-proof-concept-clinical-trial-women\" target=\"_blank\">announcement</a> of positive interim results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02658448?term=enobosarm&amp;rank=1\" target=\"_blank\">Phase 2 proof-of-concept study</a> assessing enobosarm (GTx-024) for the treatment of postmenopausal women with stress urinary incontinence &#40;SUI&#41;. The data will be presented at the International Continence Society's Annual Meeting in Florence September 12 - 15.</li><li>Clinical results from seven patients who completed 12 weeks of treatment with enobosarm experienced a mean 80.9% decrease from baseline in stress leaks, from an average of 5.7/day to 1.1/day. All participants experienced at least a 65% reduction in stress leaks.</li><li>Reductions in incontinence episodes persisted beyond the 12-week treatment period (up to five months).</li><li>According to ClinicalTrials.gov, the estimated final data collection date for the primary endpoint is October.</li><li><a href=\"http://www.gtxinc.com/Pipeline/OstarineMK2866.aspx?Sid=4\" target=\"_blank\">Enobosarm</a>&nbsp;is a non-steroidal androgen receptor agonist also being investigated for the treatment of endocrine-sensitive advanced breast cancer prior to chemotherapy.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3272826\" data-linked=\"GTx&#39;s enobosarm shows treatment effect in mid-stage study in postmenopausal women with stress urinary incontinence; shares up 14% premarket\" data-tweet=\"$GTXI $ONCT - GTx&#39;s enobosarm shows treatment effect in mid-stage study in postmenopausal women with stress urinary incontinence; shares up 14% premarket https://seekingalpha.com/news/3272826-gtxs-enobosarm-shows-treatment-effect-in-mid-stage-study-in-postmenopausal-women-stress?source=tweet\" data-url=\"https://seekingalpha.com/news/3272826-gtxs-enobosarm-shows-treatment-effect-in-mid-stage-study-in-postmenopausal-women-stress\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272825\" data-ts=\"1497268932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATDRY\" target=\"_blank\">ATDRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272825-auto-trader-group-falls-on-amazon-threat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto Trader Group falls on Amazon threat</a></h4><ul> <li>Shares of Auto Trader Group (<a href='https://seekingalpha.com/symbol/ATDRY' title='Auto Trader Group Plc. ADR'>OTCPK:ATDRY</a>, <a href='https://seekingalpha.com/symbol/ATDRF' title='Auto Trader Group Plc.'>OTC:ATDRF</a>) are <font color='red'>down 5.07%</font> in London trading after Automobilwoche reports that Amazon plans to sell cars in Europe.</li> <li>The U.K., where Auto Trader is based, is expected to be test market for the Seattle e-commerce giant.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3272825\" data-linked=\"Auto Trader Group falls on Amazon threat\" data-tweet=\"$ATDRY $ATDRY $ATDRF - Auto Trader Group falls on Amazon threat https://seekingalpha.com/news/3272825-auto-trader-group-falls-on-amazon-threat?source=tweet\" data-url=\"https://seekingalpha.com/news/3272825-auto-trader-group-falls-on-amazon-threat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272815\" data-ts=\"1497267912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGLS\" target=\"_blank\">RGLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272815-regulus-bails-on-hcv-candidate-rgminus-101-shares-down-35-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regulus bails on HCV candidate RG-101; shares down 35% premarket</a></h4><ul><li>Nano cap Regulus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a>) slumps&nbsp;<font color='red'>35%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16858458-regulus-announces-pipeline-updates-advancements\" target=\"_blank\">announcement </a>that it will discontinue development of HCV candidate RG-101 due to safety issues, specifically abnormally high levels of bilirubin in the blood. The company says impaired baseline bilirubin transport in HCV patients and the preferential uptake of RG-101 by liver cells contributed to the problem. The FDA placed the IND on clinical hold in June 2016 after a second case of jaundice was observed in a Phase 1 study.</li><li>Also, AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a>)&nbsp;has informed the company that it intends to terminate clinical development of NASH candidate RG-125 (AZD4076). All rights will revert back to Regulus in 12 months.</li><li>AZN is down a fraction premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272815\" data-linked=\"Regulus bails on HCV candidate RG-101; shares down 35% premarket\" data-tweet=\"$RGLS $RGLS $AZN - Regulus bails on HCV candidate RG-101; shares down 35% premarket https://seekingalpha.com/news/3272815-regulus-bails-on-hcv-candidate-rgminus-101-shares-down-35-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3272815-regulus-bails-on-hcv-candidate-rgminus-101-shares-down-35-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272814\" data-ts=\"1497266976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHRS\" target=\"_blank\">CHRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272814-fda-rejects-coherus-marketing-application-for-neulasta-biosimilar-shares-down-34-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA rejects Coherus&#39; marketing application for Neulasta biosimilar; shares down 34% premarket</a></h4><ul><li>Coherus BioSciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a>) has <a href=\"https://seekingalpha.com/pr/16858407-coherus-biosciences-receives-complete-response-letter-fda-biologics-license-application\" target=\"_blank\">received </a>a Complete Response Letter &#40;CRL&#41; from the FDA related to its Biologics License Application &#40;BLA&#41; seeking approval for CHS-1701, a biosimilar to Amgen's (NASDAQ:<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>) Neulasta (pegfilgrastim).</li><li>The CRL cited the need for a reanalysis of a subset of subject samples with a revised immunogenicity assay and additional manufacturing-related process information.</li><li>The company says it will work with the agency to address the issues. Management will host a conference call this morning at 8:00 am ET to discuss the situation.</li><li>Shares are down&nbsp;<font color='red'>34%</font>&nbsp;premarket on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3272814\" data-linked=\"FDA rejects Coherus&#39; marketing application for Neulasta biosimilar; shares down 34% premarket\" data-tweet=\"$CHRS $CHRS $AMGN - FDA rejects Coherus&#39; marketing application for Neulasta biosimilar; shares down 34% premarket https://seekingalpha.com/news/3272814-fda-rejects-coherus-marketing-application-for-neulasta-biosimilar-shares-down-34-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3272814-fda-rejects-coherus-marketing-application-for-neulasta-biosimilar-shares-down-34-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272811\" data-ts=\"1497266574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDXC\" target=\"_blank\">CDXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272811-chromadex-announces-patent-license-and-research-agreement-tsri-to-identify-role-of-niagen-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChromaDex announces patent license and research agreement with TSRI to identify the role of NIAGEN in treating breast cancer</a></h4><ul> <li>ChromaDex (NASDAQ:<a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a>) <a href=\"https://seekingalpha.com/pr/16858405-chromadex-announces-exclusive-worldwide-patent-license-research-agreement-scripps-research\" target=\"_blank\">announces</a> that it has signed a new, exclusive patent license and research agreement with The Scripps Research Institute, gaining access to preclinical discoveries by Dr. Brunie Felding.</li><li>Dr. Felding&rsquo;s patented discoveries include the enhancement of NAD+ metabolism through treatment with NAD+ precursors to potentiate the effects of <a href=\"http://www.webmd.com/breast-cancer/hormone-therapy-overview#1\" target=\"_blank\">endocrine therapy</a> in breast cancer, inhibit resistance of breast cancer cells to endocrine therapy, and re-instate sensitivity in breast cancer cells that are unresponsive to endocrine treatments such as Tamoxifen.</li><li>The research agreement, if successful, will yield the data and tools required for a clinical trial evaluating a combination therapy consisting of nicotinamide riboside and endocrine therapy in the treatment of breast cancer.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket on a light volume.</li>         </ul><div class=\"tiny-share-widget\" data-id=\"3272811\" data-linked=\"ChromaDex announces patent license and research agreement with TSRI to identify the role of NIAGEN in treating breast cancer\" data-tweet=\"$CDXC - ChromaDex announces patent license and research agreement with TSRI to identify the role of NIAGEN in treating breast cancer https://seekingalpha.com/news/3272811-chromadex-announces-patent-license-and-research-agreement-tsri-to-identify-role-of-niagen-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3272811-chromadex-announces-patent-license-and-research-agreement-tsri-to-identify-role-of-niagen-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3272797\" data-ts=\"1497263590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3272797-weekend-cant-stop-tech-selloff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekend can&#39;t stop tech selloff</a></h4><ul><li>It looks like the tech selloff from Friday is spilling into the Monday morning trading session despite months of sharp gains.</li><li>Goldman Sachs turned cautious on the sector, warning investors that they should not consider tech as a safe haven, while some fear it has become a massive market bubble.</li><li>On the move premarket: <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-2.6%</font>; <a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='red'>-2.2%</font>; <a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='red'>-2.1%</font>; <a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='red'>-1.7%</font>; <a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='red'>-1.2%</font>; <a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-1.2%</font>; <a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a><font color='red'> -1.2%</font>; <a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a> <font color='red'>-1.1%</font>; <a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Inc.'>TXN</a> <font color='red'>-1.1%</font>; <a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='red'>-1%</font>; <a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a> <font color='red'>-1%</font>; <a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a> <font color='red'>-0.7%</font>; <a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a> <font color='red'>-0.3%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3272797\" data-linked=\"Weekend can&#39;t stop tech selloff\" data-tweet=\"$AMD $AMD $AAPL - Weekend can&#39;t stop tech selloff https://seekingalpha.com/news/3272797-weekend-cant-stop-tech-selloff?source=tweet\" data-url=\"https://seekingalpha.com/news/3272797-weekend-cant-stop-tech-selloff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>90&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":62,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}